Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / News/  Sun Pharma says shortage of hypertension drug in US
BackBack

Sun Pharma says shortage of hypertension drug in US

Pindolol, sold under the brand name Visken by Novartis, is an orally administered drug used alone or with other medications to treat high blood pressure
  • The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies
  • Sun Pharma, however, reiterated that there had been some impact on supplies for a few APIsPremium
    Sun Pharma, however, reiterated that there had been some impact on supplies for a few APIs

    Bengaluru: Indian drugmaker Sun Pharmaceutical Industries Ltd reported a shortage of its generic version of hypertension drug pindolol in the United States due to a lack of pharmaceutical ingredients, but said the shortfall did not stem from China.

    Indian companies are the main supplier of generic drugs to the world and procure almost 70% of the active pharmaceutical ingredients (APIs) for their medicines from China.

    The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to face supply shortages from China if the epidemic drags on.

    "At the moment, we haven't seen any major disruption in API supplies due to the coronavirus outbreak in China," Sun Pharma said in an email on Monday, without giving details on the reasons for the shortfall in pindolol ingredients.

    "We have sufficient inventory of API and raw materials for the short term," it added.

    Sun Pharma, however, reiterated that there had been some impact on supplies for a few APIs, but did not identify the drugs that might be affected.

    Last week, the U.S. Food and Drug Administration announced the first coronavirus-related drug shortage in the United States, but declined to name the drug in question, leaving industry players debating which medicines were at risk.

    Pindolol, sold under the brand name Visken by Novartis, is an orally administered drug used alone or with other medications to treat high blood pressure.

    Other generic drugmakers in India say they currently have enough API supplies from China to cover their operations for up to about three months.

    Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

    This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

    Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
    More Less
    Published: 02 Mar 2020, 11:15 PM IST
    Next Story footLogo
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App